United States of America Continuous Glucose Monitoring Market is Segmented By Components (Sensors, Transmitters & Receivers, Integrated System, Others), By Demographic (Adults (18-65), Geriatrics (65+), Pediatrics/ Teenagers), By Indication (Type 1 Diabetes, Gestational Diabetes, Type 2 Diabetes, Others), By End-User (Hospitals, Home Care, Clinics, Nursing Homes, Others). The report offers the value (in USD billion) for the above-mentioned segments.
Market Size in USD
CAGR8.6%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 8.6% |
Market Concentration | Medium |
Major Players | Abbott, Dexcom, Inc., Medtronic, Senseonics, Inc., F. Hoffmann-La Roche Ltd. |
The United States of America Continuous Glucose Monitoring Market is estimated to be valued at USD 599.47 Mn in 2024 and is expected to reach USD 1,068.02 Mn by 2031, growing at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.
The continuous glucose monitoring market in the United States is expected to witness significant growth over the forecast period, owing to the increasing prevalence of diabetes in the country.